A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma
Clinical trial NCT02811679 · TERMINATED
Trial details
- NCT number
- NCT02811679
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-01-27
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.